Housley S N, Garlow A R, Ducote K, Howard A, Thomas T, Wu D, Richards K, Butler A J
Department of Physical Therapy, Georgia State University, USA.
Department of Physical Therapy, Georgia State University, USA; Department of Veteran's Affairs, Atlanta Rehabilitation Research and Development Center of Excellence, USA; Neuroscience Institute, Joint Center for Advanced Brain Imaging, Center for Behavioral Neuroscience, Georgia State University, USA.
Austin J Cerebrovasc Dis Stroke. 2016 Aug 25;3(2):1-11.
An estimated 750,000 Americans experience a stroke annually. Most stroke survivors require rehabilitation. Limited access to rehabilitation facilities has a pronounced burden on functional outcomes and quality of life. Robotic devices deliver reproducible therapy without the need for real-time human oversight. This study examined the efficacy of using home-based, telerobotic-assisted devices (Hand and Foot Mentor: HM and FM) to improve functional ability and reduce depression symptoms, while improving access and cost savings associated with rehabilitation.
Twenty stroke survivors performed three months of home-based rehabilitation using a robotic device, while a therapist remotely monitored progress. Baseline and end of treatment function and depression symptoms were assessed. Satisfaction with the device and access to therapy were determined using qualitative surveys. Cost analysis was performed to compare home-based, robotic-assisted therapy to clinic-based physical therapy.
Compared to baseline, significant improvement in upper extremity function (30.06%, p= 0.046), clinically significant benefits in gait speed (29.03%), moderate improvement in depressive symptoms (28.44%) and modest improvement in distance walked (30.2%) were observed. Participants indicated satisfaction with the device. Home-based robot therapy expanded access to post-stroke rehabilitation for 35% of the people no longer receiving formal services and increased daily access for the remaining 65%, with a cost savings of $2,352 (64.97%) compared to clinic-based therapy.
Stroke survivors made significant clinically meaningful improvements in the use of their impaired extremities using a robotic device in the home. Home-based, robotic therapy reduced costs, while expanding access to a rehabilitation modality for people who would not otherwise have received care.
据估计，每年有75万美国人罹患中风。大多数中风幸存者需要康复治疗。康复设施获取机会有限对功能结局和生活质量造成了显著负担。机器人设备可提供可重复的治疗，无需实时人工监督。本研究探讨了使用居家远程机器人辅助设备（手部和足部康复训练仪：HM和FM）改善功能能力、减轻抑郁症状，同时改善康复治疗的可及性并节省成本的效果。
20名中风幸存者使用机器人设备进行了为期三个月的居家康复治疗，同时治疗师远程监测进展情况。评估了基线及治疗结束时的功能和抑郁症状。通过定性调查确定对设备的满意度和治疗可及性。进行成本分析以比较居家机器人辅助治疗与门诊物理治疗。
与基线相比，观察到上肢功能有显著改善（30.06%，p = 0.046），步态速度有临床显著改善（29.03%），抑郁症状有中度改善（28.44%），步行距离有适度改善（30.2%）。参与者表示对设备满意。居家机器人治疗使35%不再接受正规服务的人群有机会接受中风后康复治疗，并使其余65%的人群增加了每日治疗机会，与门诊治疗相比节省成本2352美元（64.97%）。
中风幸存者在家中使用机器人设备对其受损肢体的使用有显著的临床意义上的改善。居家机器人治疗降低了成本，同时为那些原本无法获得治疗的人群增加了康复治疗方式的可及性。
